Du är här


Myriad Genetics, Inc.: /K I L L K I L L K I L L -- Myriad Genetics, Inc.

SALT LAKE CITY, April 7, 2014 (GLOBE NEWSWIRE) -- Please be advised that
journalists and other readers should disregard the news release, "Myriad
Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)" issued April
7, 2014 by Myriad Genetics, Inc., over GlobeNewswire.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Myriad Genetics, Inc. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.